217.75
0.45 (0.21%)
| Previous Close | 217.30 |
| Open | 213.82 |
| Volume | 1,088,137 |
| Avg. Volume (3M) | 1,114,826 |
| Market Cap | 35,351,711,744 |
| Price / Earnings (TTM) | 53.77 |
| Price / Earnings (Forward) | 32.57 |
| Price / Sales | 14.04 |
| Price / Book | 6.68 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | 23.91% |
| Operating Margin (TTM) | 24.62% |
| Diluted EPS (TTM) | 4.05 |
| Quarterly Revenue Growth (YOY) | 14.60% |
| Quarterly Earnings Growth (YOY) | 53.20% |
| Total Debt/Equity (MRQ) | 1.04% |
| Current Ratio (MRQ) | 5.01 |
| Operating Cash Flow (TTM) | 996.76 M |
| Levered Free Cash Flow (TTM) | 804.47 M |
| Return on Assets (TTM) | 6.39% |
| Return on Equity (TTM) | 13.18% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Veeva Systems Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | -3.0 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.0 |
| Average | -0.50 |
|
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Mid Growth |
| % Held by Insiders | 8.94% |
| % Held by Institutions | 83.88% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 307.00 (Citigroup, 40.99%) | Buy |
| Median | 272.00 (24.91%) | |
| Low | 195.00 (Morgan Stanley, -10.45%) | Sell |
| Average | 262.94 (20.75%) | |
| Total | 10 Buy, 6 Hold, 1 Sell | |
| Avg. Price @ Call | 242.83 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 13 Jan 2025 | 210.00 (-3.56%) | Hold | 212.84 |
| 06 Dec 2024 | 261.00 (19.86%) | Hold | 250.45 | |
| Keybanc | 08 Jan 2025 | 255.00 (17.11%) | Buy | 217.30 |
| Morgan Stanley | 17 Dec 2024 | 195.00 (-10.45%) | Sell | 226.41 |
| JP Morgan | 16 Dec 2024 | 218.00 (0.11%) | Hold | 224.69 |
| Citigroup | 09 Dec 2024 | 307.00 (40.99%) | Buy | 245.99 |
| Mizuho | 09 Dec 2024 | 280.00 (28.59%) | Buy | 245.99 |
| 04 Dec 2024 | 275.00 (26.29%) | Buy | 237.74 | |
| B of A Securities | 06 Dec 2024 | 290.00 (33.18%) | Hold | 250.45 |
| Baird | 06 Dec 2024 | 283.00 (29.97%) | Buy | 250.45 |
| 28 Oct 2024 | 245.00 (12.51%) | Buy | 212.13 | |
| Barclays | 06 Dec 2024 | 275.00 (26.29%) | Buy | 250.45 |
| 08 Nov 2024 | 260.00 (19.40%) | Buy | 235.00 | |
| Canaccord Genuity | 06 Dec 2024 | 270.00 (24.00%) | Hold | 250.45 |
| Evercore ISI Group | 06 Dec 2024 | 245.00 (12.51%) | Hold | 250.45 |
| Needham | 06 Dec 2024 | 270.00 (24.00%) | Buy | 250.45 |
| 08 Nov 2024 | 260.00 (19.40%) | Buy | 235.00 | |
| Piper Sandler | 06 Dec 2024 | 290.00 (33.18%) | Buy | 250.45 |
| 08 Nov 2024 | 280.00 (28.59%) | Buy | 235.00 | |
| RBC Capital | 06 Dec 2024 | 285.00 (30.88%) | Buy | 250.45 |
| 08 Nov 2024 | 275.00 (26.29%) | Buy | 235.00 | |
| Scotiabank | 06 Dec 2024 | 240.00 (10.22%) | Hold | 250.45 |
| 18 Nov 2024 | 235.00 (7.92%) | Hold | 213.68 | |
| Stifel | 06 Dec 2024 | 272.00 (24.91%) | Buy | 250.45 |
| Wells Fargo | 06 Dec 2024 | 285.00 (30.88%) | Buy | 250.45 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DIAMOND KRISTINE | - | 210.25 | -84 | -17,661 |
| FADDIS JONATHAN | - | 210.25 | -445 | -93,561 |
| SCHWENGER THOMAS D. | - | 210.25 | -593 | -124,678 |
| VAN WAGENER BRIAN | - | 210.25 | -477 | -100,289 |
| ZUPPAS ELENI NITSA | - | 210.25 | -517 | -108,699 |
| Aggregate Net Quantity | -2,116 | |||
| Aggregate Net Value ($) | -444,889 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 210.25 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FADDIS JONATHAN | Officer | 01 Jan 2025 | Disposed (-) | 445 | 210.25 | 93,561 |
| FADDIS JONATHAN | Officer | 01 Jan 2025 | Option execute | 1,120 | - | - |
| ZUPPAS ELENI NITSA | Officer | 01 Jan 2025 | Disposed (-) | 517 | 210.25 | 108,699 |
| ZUPPAS ELENI NITSA | Officer | 01 Jan 2025 | Option execute | 1,323 | - | - |
| DIAMOND KRISTINE | Officer | 01 Jan 2025 | Disposed (-) | 84 | 210.25 | 17,661 |
| DIAMOND KRISTINE | Officer | 01 Jan 2025 | Option execute | 203 | - | - |
| SCHWENGER THOMAS D. | Officer | 01 Jan 2025 | Disposed (-) | 593 | 210.25 | 124,678 |
| SCHWENGER THOMAS D. | Officer | 01 Jan 2025 | Option execute | 1,909 | - | - |
| VAN WAGENER BRIAN | Officer | 01 Jan 2025 | Disposed (-) | 477 | 210.25 | 100,289 |
| VAN WAGENER BRIAN | Officer | 01 Jan 2025 | Option execute | 1,370 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |